ClinVar Miner

Submissions for variant NM_002834.5(PTPN11):c.235C>A (p.Gln79Lys) (rs397516803)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000037640 SCV000061302 likely pathogenic Noonan syndrome 2013-01-28 criteria provided, single submitter clinical testing The Gln79Lys variant in PTPN11 has been identified by our laboratory in three af fected individuals in from a family with clinical features of Noonan syndrome. W hile this variant has not been reported in the literature, two different amino a cid changes at this position have been reported and identified by our laboratory in many individuals with clinical features of Noonan syndrome (Gln79Arg, Gln79P ro; Karbach 2011, Sarkozy 2003, Tartaglia 2006). At least two of these cases occ urred de novo (Sarkozy 2003). Computational analyses (biochemical amino acid pro perties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong sup port for or against an impact to the protein. In summary, this variant is likely pathogenic based on the presence of other pathogenic variants at this position and the segregation of this variant in family members, though additional studies are required to fully establish its clinical significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.